MitraClip Can Improve Outcomes in Patients with Both Mitral and Tricuspid Regurgitation, Study Shows
In an analysis of patients from the COAPT trial with severe mitral regurgitation (MR) who have heart failure and tricuspid regurgitation (TR), treatment with MitraClip plus guideline-directed medical therapy (GDMT) led to more favorable prognoses compared to GDMT alone.